Loading clinical trials...
Loading clinical trials...
A PHASE 1, RANDOMIZED, OPEN-LABEL, CROSS-OVER, SINGLE-DOSE STUDY TO EVALUATE THE BIOEQUIVALENCE OF CANDIDATE CAPSULE FORMULATIONS OF PF-06651600 TO TABLETS AND ESTIMATE THE EFFECT OF HIGH-FAT MEAL ON BIOAVAILABILITY IN HEALTHY PARTICIPANTS
Conditions
Interventions
PF-06651600
Locations
2
United States
Research Centers of America ( Hollywood )
Hollywood, Florida, United States
Prism Research LLC dba Nucleus Network
Saint Paul, Minnesota, United States
Start Date
September 28, 2020
Primary Completion Date
July 19, 2021
Completion Date
July 19, 2021
Last Updated
August 4, 2021
NCT06342713
NCT07310901
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions